Iovance Biotherapeutics Inc (IOVA) — Tangible Net Worth Ratio
Iovance Biotherapeutics Inc (IOVA) has a Tangible Net Worth Ratio of 59.4% as of September 2025. This metric is calculated by deducting intangible assets ($285.21 Million) from net assets ($702.29 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore IOVA net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Iovance Biotherapeutics Inc Tangible Net Worth Ratio (2008–2024)
This chart shows how Iovance Biotherapeutics Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 59.4%, reflecting net assets of $702.29 Million with intangible assets of $285.21 Million USD. For live market cap and overall valuation, see how much is Iovance Biotherapeutics Inc worth.
Annual Tangible Net Worth Ratio for Iovance Biotherapeutics Inc (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Iovance Biotherapeutics Inc from 2008 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See cash generation quality of Iovance Biotherapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 60.2% | $710.40 Million | $282.40 Million | $910.43 Million | ▼ -0.5 pp |
| 2023 | 60.8% | $584.61 Million | $229.26 Million | $780.35 Million | ▼ -39.2 pp |
| 2022 | 100.0% | $499.64 Million | $0.00 | $663.98 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $621.66 Million | $0.00 | $777.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $656.50 Million | $0.00 | $768.46 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $298.97 Million | $0.00 | $344.65 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $466.19 Million | $0.00 | $480.82 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $145.48 Million | $0.00 | $155.37 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $166.92 Million | $0.00 | $171.89 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $104.02 Million | $0.00 | $105.65 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $44.85 Million | $0.00 | $46.51 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $17.60 Million | $0.00 | $19.87 Million | ▲ +25.1 pp |
| 2010 | 74.9% | $638.09K | $160.04K | $1.46 Million | ▼ -25.1 pp |
| 2008 | 100.0% | $2.28K | $0.00 | $5.61K | — |